Ruth March
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
-
- Computational Drug Discovery Methods
Papers in
- Genetics 9
- Genomics and Rare Diseases 3
- Genetic Associations and Epidemiology 3
-
- Biosimilars and Bioanalytical Methods 3
- Co-authors
- Menelas N. Pangalos (2 shared papers)Paul Morgan (2 shared papers)David Cook (1 shared paper)Dearg S. Brown (1 shared paper)Robert Alexander (1 shared paper)Dennis W. Schneck (1 shared paper)Helen Ambrose (1 shared paper)S RYAN (1 shared paper)
- Journals
- Pharmacogenomics (3 papers)Yeast (2 papers)Nature Reviews Drug Discovery (2 papers)Atherosclerosis Supplements (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Ruth March
30 papers receiving 2.2k citations
Ruth March's Hit Papers
Peers
Comparison fields: 5 of 133
- Pharmacology 274
- Computational Theory and Mathematics 376
- Immunology 298
- Rheumatology 176
- Oncology 259
Countries citing papers authored by Ruth March
This map shows the geographic impact of Ruth March's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth March with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth March more than expected).
Fields of papers citing papers by Ruth March
This network shows the impact of papers produced by Ruth March. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth March. The network helps show where Ruth March may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth March, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework Hit paper breakdown → | 2014 | 1007 |
| 2 | 2005 | 381 | |
| 3 | Impact of a five-dimensional framework on R&D productivity at AstraZeneca Hit paper breakdown → | 2018 | 302 |
| 4 | 1998 | 120 | |
| 5 | 2004 | 78 | |
| 6 | 1998 | 68 | |
| 7 | 2006 | 50 | |
| 8 | 2001 | 39 | |
| 9 | 2000 | 36 | |
| 10 | 2002 | 26 | |
| 11 | 2000 | 23 | |
| 12 | 1995 | 23 | |
| 13 | 1999 | 19 | |
| 14 | 1959 | 18 | |
| 15 | 1956 | 17 | |
| 16 | 2022 | 16 | |
| 17 | 2005 | 11 | |
| 18 | 2010 | 11 | |
| 19 | 2011 | 9 | |
| 20 | 2001 | 8 |
About Ruth March
Ruth March is a scholar working on Genetics, Immunology, Molecular Biology, Computational Theory and Mathematics and Pharmacology, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmaceutical Economics and Policy (3 papers), Genomics and Rare Diseases (3 papers), Statistical Methods in Clinical Trials (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Genetic Associations and Epidemiology (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Pharmacology (274 citations), Computational Theory and Mathematics (376 citations), Immunology (298 citations), Rheumatology (176 citations) and Oncology (259 citations). Ruth March has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Menelas N. Pangalos, Paul Morgan, David Cook, Dearg S. Brown, Robert Alexander, Dennis W. Schneck, Helen Ambrose, S RYAN, Eminy H.Y. Lee and Bruce K. Birmingham. Their work appears in journals such as Pharmacogenomics, Yeast, Nature Reviews Drug Discovery, Atherosclerosis Supplements and Journal of Histochemistry & Cytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.